in-vitro population bioequivalence [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2019-02-06 09:55 (2343 d 01:40 ago) – Posting: # 19879
Views: 2,573

Hi kumarnaidu,

❝ We have conducted the Beclomethasone in-vitro population bioequivalence study for spray pattern test. Ten units for three batch of test and reference products were used for beginning life stage only.


❝ In this experiment, three reading were measured each canisters of beginning life stage only (m=1). My question is such case, n: Number of canisters or bottles per batch, for T and R products would be 10 or 30.


n is the number of units per batch; in this case it sounds like you have n=10. This is usually not enough to secure a reasonable chance to show BE for nasal products and inhaled products (regardless of pMDI, DPI or nebs).

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,681 registered users;
66 visitors (0 registered, 66 guests [including 16 identified bots]).
Forum time: 12:36 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5